Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Neoplasms of the CNS

Free Subscription 10.08.2026 1 Acta Neuropathol 3 AJNR Am J Neuroradiol 1 BMC Neurol 6 Childs Nerv Syst 1 Clin Cancer Res 12 J Neurooncol 1 J Neurosurg 1 Nat Rev Neurol 6 Neuro Oncol 1 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. TIWARI A, Pawlowski KD, Balyasnikova IV
   Improving T-cell engager efficacy in glioblastoma with multi-antigen targeting and novel delivery approaches.
   Acta Neuropathol. 2026;152:15.
   PubMed         Abstract available
   
   

   
   AJNR Am J Neuroradiol

2. REECHER HM, Duenweg SR, Lowman AK, Winiarz A, et al
   A Comparison of Radio-Pathomic, Diffusion, and Perfusion Imaging Features for Identifying Pseudoprogression in Glioblastoma.
   AJNR Am J Neuroradiol. 2026 Aug 7:ajnr.A9574. doi: 10.3174/ajnr.A9574.
   PubMed         Abstract available
   
   
3. MARK IT, Nickel D, Kollasch P, Dueker K, et al
   Contrast-Enhanced T2-Weighted STIR Imaging of Pituitary Adenomas.
   AJNR Am J Neuroradiol. 2026;47:2160-2162.
   PubMed         Abstract available
   
   
4. DAGHER R, Sun P, Al Qudah H, Kaya D, et al
   Dynamic Susceptibility Contrast MRI Using Gadopiclenol for Evaluation of Relative Cerebral Blood Volume at 3T: A Comparison with Gadobutrol.
   AJNR Am J Neuroradiol. 2026;47:2181-2186.
   PubMed         Abstract available
   
   

   
   BMC Neurol

5. SECEN AE, Guresci S, Ozbakir MO, Gunduz UK, et al
   Clinical presentation and survival outcome of solitary fibrous tumors of the central nervous system: a single center study.
   BMC Neurol. 2026;26:499.
   PubMed         Abstract available
   
   

   
   Childs Nerv Syst

6. MORITA K, Nakashima Y, Kurose N, Kawashima A, et al
   Intraoperative diagnosis of myxoid glioneuronal tumor guiding safe limited resection: a case report.
   Childs Nerv Syst. 2026;42:319.
   PubMed         Abstract available
   
   
7. ABDALLAH AM, Hulliel AF, Saleh D, Mukahal M, et al
   Successful pre-operative endovascular intraventricular meningioma embolization: a systematic review and pediatric case analysis.
   Childs Nerv Syst. 2026;42:320.
   PubMed         Abstract available
   
   
8. VIRGIN KL, Fletcher M, Ayub J, Harmsen H, et al
   Time to adjuvant treatment for newly diagnosed pediatric brain tumors in the molecular era: a single center retrospective study.
   Childs Nerv Syst. 2026;42:322.
   PubMed         Abstract available
   
   
9. KAHRAMAN S, Cal MA
   Unilateral hemilaminectomy for pediatric intradural spinal tumors: a consecutive case series.
   Childs Nerv Syst. 2026;42:321.
   PubMed         Abstract available
   
   
10. DIXIT S, Kumar A, Datta A, Tripathi D, et al
    Postoperative meningitis in pediatric posterior fossa tumors: risk stratification and the role of early CSF cytology.
    Childs Nerv Syst. 2026;42:324.
    PubMed         Abstract available
    
    
11. LI L, Zhang J, Wu W
    Second primary malignancies among childhood medulloblastoma survivors: a population-based competing risk analysis.
    Childs Nerv Syst. 2026;42:326.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

12. KIM K, Song SW, Jeon Y, Choi S, et al
    Phase I trial of IL13Ralpha2-targeted CAR-T cell therapy for recurrent malignant glioma: clinical results and pharmacokinetics.
    Clin Cancer Res. 2026 Aug 4. doi: 10.1158/1078-0432.CCR-26-0645.
    PubMed         Abstract available
    
    

    
    J Neurooncol

13. NIRANJAN A, Reyes JS, Hadjipanayis CG, Bernstein K, et al
    Stereotactic radiosurgery offers long-term tumor control for craniopharyngioma: a multi-institutional analysis of clinical and imaging outcomes from the International Radiosurgery Research Foundation (IRRF).
    J Neurooncol. 2026;179:24.
    PubMed         Abstract available
    
    
14. JU K, Park JE, Mahmud SZ, Blair L, et al
    Multi-molecular saturation-transfer MR fingerprinting for differentiating tumor progression from treatment-related change in post-treatment IDH-wildtype glioblastoma: a feasibility study.
    J Neurooncol. 2026;179:25.
    PubMed         Abstract available
    
    
15. BEGAGIC E, Beculic H, Harcinovic AK, Huseinspahic N, et al
    Brain metastases in triple-negative breast cancer: a systematic review of current trends, treatment strategies, and outcomes.
    J Neurooncol. 2026;179:27.
    PubMed         Abstract available
    
    
16. BAKOS J, Stangl F, Behrens L, Berlis A, et al
    The risk of sinus vein thrombosis in patients treated with intraoperative radiotherapy for sinus adjacent tumours.
    J Neurooncol. 2026;179:26.
    PubMed         Abstract available
    
    
17. DESAI A, Malik M, Cook CJ, Fei-Zhang DJ, et al
    Individual and community-level associations of social determinants with pituitary adenoma disparities in the US.
    J Neurooncol. 2026;179:29.
    PubMed         Abstract available
    
    
18. TRKOVA K, Vicha A, Sumerauer D, Ghasemi DR, et al
    Pediatric ependymoma in the molecular era: real-world experience with diagnostic correlation and long-term clinical outcomes.
    J Neurooncol. 2026;179:30.
    PubMed         Abstract available
    
    
19. SCHMIDT L, Santaniello SD, Krenzlin H, Kronfeld A, et al
    DTI-ALPS is not independently associated with overall survival beyond established prognostic factors in glioblastoma.
    J Neurooncol. 2026;179:33.
    PubMed         Abstract available
    
    
20. MAKHLOUF N, Zehani A, Kallel J, Chelly I, et al
    CD34 and p16 expression in central nervous system solitary fibrous tumors: an exploratory clinicopathologic study.
    J Neurooncol. 2026;179:32.
    PubMed         Abstract available
    
    
21. SYED SA, Coppin FM, Latzman S, Teng CL, et al
    Longitudinal connectomics-based tractometry for characterizing white matter reorganization following brain tumor surgery: a proof-of-concept case series.
    J Neurooncol. 2026;179:28.
    PubMed         Abstract available
    
    
22. PATEL CB, Robinson TJ, Kurz SC, Ginat DT, et al
    Distinguishing true progression from treatment effects in glioblastoma: a practical, evidence-graded imaging framework for the multidisciplinary team.
    J Neurooncol. 2026;179:34.
    PubMed         Abstract available
    
    
23. HOUNCHONOU HF, Polemikos M, Pirayesh A, Bajgora G, et al
    Molecularly diagnosed glioblastoma: clinical presentation and outcomes.
    J Neurooncol. 2026;179:35.
    PubMed         Abstract available
    
    
24. KRIGERS A, Demetz M, Bergmeister L, Moser P, et al
    Actin, connexin-43 and GAP-43 expression in gliomas: real-world associations with IDH status, tumor burden and survival.
    J Neurooncol. 2026;179:36.
    PubMed         Abstract available
    
    

    
    J Neurosurg

25. LU W, Liu Y, Wu X, Ma L, et al
    Metabolic boundary resection of glioblastoma correlates with clinical outcome and survival analysis: a comparative cohort study.
    J Neurosurg. 2026 Aug 7:1-10. doi: 10.3171/2026.3.JNS252582.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

26. KIANI L
    Tumour and microenvironment targeting of glioblastoma with dual-acting CAR T cells.
    Nat Rev Neurol. 2026 Aug 5. doi: 10.1038/s41582-026-01254.
    PubMed        
    
    

    
    Neuro Oncol

27. ELGUINDY M, Raleigh DR
    Focused ultrasound to track circulating extracellular vesicles in glioblastoma.
    Neuro Oncol. 2026 Aug 6:noag184. doi: 10.1093.
    PubMed        
    
    
28. LIU M, Wang H, Guo J, Li X, et al
    Multi-transcriptomics analysis identifies NNAT as a key molecule driving the invasive phenotype across all lineages of pituitary adenomas.
    Neuro Oncol. 2026;28:1953-1969.
    PubMed         Abstract available
    
    
29. ZARAGORI T, Rozenblum L, Rovera G, Stien G, et al
    Automatic extraction of PET RANO criteria with an externally validated deep learning model: Application to [18F]FDOPA PET imaging.
    Neuro Oncol. 2026;28:2053-2064.
    PubMed         Abstract available
    
    
30. CHO M, Kim M, Kim H, Choi K, et al
    A comprehensive clinical, molecular, radiological, and surgical analysis for predicting prognosis in isocitrate dehydrogenase-mutant astrocytoma patients.
    Neuro Oncol. 2026;28:2016-2029.
    PubMed         Abstract available
    
    
31. ZHAO L, Clark PA, Shireman JM, Schepp CL, et al
    Radiopharmaceutical therapy provides superior survival advantage for leptomeningeal metastasis compared to external beam radiotherapy.
    Neuro Oncol. 2026;28:1986-1998.
    PubMed         Abstract available
    
    
32. VIRATA MC, Samanamud J, Slocum CC, Kandoi S, et al
    Expanding the molecular grading criteria in IDH-mutant astrocytoma.
    Neuro Oncol. 2026;28:1921-1932.
    PubMed         Abstract available
    
    

    
    PLoS One

33. GONG B, Liu S, Chen S, Yu L, et al
    Association between preoperative chronic steroid use and pulmonary embolism in adult tumor craniotomy: Linking role of platelet-to-white blood cell ratio.
    PLoS One. 2026;21:e0355416.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

34. 
    Retraction for Khan et al., Macrophage TBK1 signaling drives the development and outgrowth of breast cancer brain metastasis.
    Proc Natl Acad Sci U S A. 2026;123:e2625886123.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum